Overview

BAY38-9456, 5/10/20mg, vs.Placebo in Erectile Dysfunction

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
Purpose of the study is:- To assess the efficacy and tolerability of vardenafil in male subjects suffering from erectile dysfunction as compared to placebo- To assess the influence of vardenafil on the self-esteem and self-confidence of subjects suffering from erectile dysfunction following treatment with vardenafil as compared to placebo
Phase:
Phase 4
Details
Lead Sponsor:
Bayer
Collaborator:
GlaxoSmithKline
Treatments:
Vardenafil Dihydrochloride